Welcome to NexGen Biotech! We specialize in providing high-quality molecular reagents for all types of PCR testing. Our mission is to empower reference laboratories and physician-owned labs with reliable, cutting-edge solutions that enhance diagnostic capabilities.
At NexGen Biotech, we understand the critical role that accurate testing plays in patient care. That’s why we offer a comprehensive range of molecular reagents designed to meet the diverse needs of the healthcare sector. Our turnkey solutions enable physician-owned labs to streamline their operations and deliver timely, precise results to their patients.
We take pride in our commitment to excellence, guaranteeing the best pricing in the industry without compromising on quality. Our team of experts is dedicated to supporting your laboratory's success, helping you navigate the complexities of PCR testing with confidence.
Join us on this journey toward advancing molecular diagnostics. Let’s work together to improve patient outcomes and elevate the standards of healthcare. Connect with us today at NexGen Biotech!
Company Details
- Employees
- 2
- Founded
- -
- Address
- 4300 Belmont Ave, Youngstown,ohio 44505,united States
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- https://nxgbiotech.com/
- HQ
- Youngstown, Ohio
Nexgen Biotech Questions
Nexgen Biotech's website is https://nxgbiotech.com/
Nexgen Biotech's LinkedIn profile is https://www.linkedin.com/company/nexgen-biotech
Nexgen Biotech has
2 employees.
View email and phone details for 2
employees at Nexgen Biotech.
Nexgen Biotech's industry is
Medical and Diagnostic Laboratories
Nexgen Biotech's top competitors are
Purpose The Therapeutic Subscription Box, Llc,
Mayo Realtors,
Medical Technology Group Llc,
Marinabiolab,
Mesh.,
Genedx,
Nexgen Lab, Llc,
Optimize Health,
Nexgen Labs,
The Beauty Of Benefits.
Nexgen Biotech's categories are Medical and Diagnostic Laboratories
Nexgen Biotech's founding year is 2019
